Skip to main content
EKSO
NASDAQ Technology

Ekso Bionics Announces Transformational Acquisition, 38x Dilution, and Change of Control to Applied Digital Cloud

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
10
Price
$9.87
Mkt Cap
$33.486M
52W Low
$2.73
52W High
$12.7
Market data snapshot near publication time

summarizeSummary

Ekso Bionics announced a business combination with Applied Digital Cloud Corporation, leading to extreme dilution for existing shareholders and a change of control, alongside dire preliminary financial results and significant governance changes.


check_boxKey Events

  • Transformational Business Combination Announced

    Ekso Bionics Holdings, Inc. entered into a Contribution and Exchange Agreement to acquire Applied Digital Cloud Corporation. Post-closing, Ekso will change its name to ChronoScale Corporation.

  • Extreme Share Dilution and Change of Control

    The transaction involves issuing 138,216,820 new shares to the Contributor (APLD ChronoScale HoldCo LLC), which is expected to result in the Contributor owning approximately 97% of the combined company. This represents an approximate 38.8x dilution for existing shareholders.

  • New Equity Incentive Plan Authorizes Significant Shares

    The Board approved a new 2026 Omnibus Equity Incentive Plan, authorizing 22,500,000 shares of common stock for issuance, subject to stockholder approval. This represents substantial additional dilution for existing shareholders.

  • Deteriorating Preliminary Financial Results

    Preliminary Q4 2025 results show total revenue of $3.0M-$3.1M (down from $5.1M in Q4 2024), estimated cash of $1.2M as of Dec 31, 2025 (excluding a recent $5.3M private placement), and $4.3M net cash used in operations for the quarter, indicating a precarious financial position.


auto_awesomeAnalysis

This filing details a highly dilutive business combination where Ekso Bionics will acquire Applied Digital Cloud Corporation, resulting in existing Ekso shareholders owning a tiny fraction of the combined entity. The transaction is driven by Ekso's deteriorating financial position, as evidenced by preliminary Q4 2025 results showing a sharp revenue decline, critically low cash, and increased cash burn. The extensive governance changes, including a new equity plan authorizing millions of shares and charter amendments that entrench the new controlling shareholder (Applied Digital) while significantly reducing minority shareholder rights, fundamentally alter the investment thesis for current shareholders.

At the time of this filing, EKSO was trading at $9.87 on NASDAQ in the Technology sector, with a market capitalization of approximately $33.5M. The 52-week trading range was $2.73 to $12.70. This filing was assessed with negative market sentiment and an importance score of 10 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed EKSO - Latest Insights

EKSO
Apr 28, 2026, 5:21 PM EDT
Source: Wiseek News
Importance Score:
8
EKSO
Apr 03, 2026, 5:05 PM EDT
Filing Type: DEF 14C
Importance Score:
9
EKSO
Apr 02, 2026, 8:08 PM EDT
Filing Type: PRER14C
Importance Score:
9
EKSO
Mar 30, 2026, 7:38 PM EDT
Filing Type: PRER14C
Importance Score:
9
EKSO
Mar 20, 2026, 5:13 PM EDT
Filing Type: PREM14C
Importance Score:
9
EKSO
Feb 23, 2026, 4:06 PM EST
Filing Type: 10-K
Importance Score:
10
EKSO
Feb 20, 2026, 4:57 PM EST
Filing Type: 4
Importance Score:
7
EKSO
Feb 17, 2026, 3:42 PM EST
Filing Type: 4
Importance Score:
8
EKSO
Feb 17, 2026, 6:07 AM EST
Filing Type: DEFA14A
Importance Score:
10
EKSO
Feb 17, 2026, 6:06 AM EST
Filing Type: 8-K
Importance Score:
10